Binding molecules against SARS-coronavirus and uses thereof
US7696330B2 · kind B2 · utility
56Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2006 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Feb 3, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/165
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides binding molecules that specifically bind to SARS-CoV, nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules are capable of specifically binding to SARS-CoV and can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from SARS-CoV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.